BMGL (Basel Medical Group Ltd Ordinary Shares) Stock Analysis - AI Report

Basel Medical Group Ltd Ordinary Shares (BMGL) is a publicly traded Healthcare sector company. As of May 21, 2026, BMGL trades at $0.63 with a market cap of $12.39M and a P/E ratio of 0.00. BMGL moved +0.00% today. Year to date, BMGL is +9.49%; over the trailing twelve months it is -67.59%. Its 52-week range spans $0.49 to $9.40. Rallies surfaces BMGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on BMGL?

Rallies AI research for BMGL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

BMGL Key Metrics

Key financial metrics for BMGL
MetricValue
Price$0.63
Market Cap$12.39M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$9.40
52-Week Low$0.49
Volume2
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BMGL News

BMGL Analyst Consensus

BMGL analyst coverage data. Average price target: $0.00.

Common questions about BMGL

What is the AI research view on BMGL?
Rallies AI research for BMGL combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for BMGL?
Rallies AI research for BMGL combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is BMGL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BMGL. It does not provide personalized investment advice.
BMGL

BMGL